167 related articles for article (PubMed ID: 9702775)
21. Transfer of the feline erythropoietin gene to cats using a recombinant adeno-associated virus vector.
Beall CJ; Phipps AJ; Mathes LE; Stromberg P; Johnson PR
Gene Ther; 2000 Mar; 7(6):534-9. PubMed ID: 10757028
[TBL] [Abstract][Full Text] [Related]
22. Rapamycin control of transgene expression from a single AAV vector in mouse salivary glands.
Wang J; Voutetakis A; Papa M; Rivera VM; Clackson T; Lodde BM; Mineshiba F; Baum BJ
Gene Ther; 2006 Jan; 13(2):187-90. PubMed ID: 16177817
[TBL] [Abstract][Full Text] [Related]
23. Inducible long-term gene expression in brain with adeno-associated virus gene transfer.
Haberman RP; McCown TJ; Samulski RJ
Gene Ther; 1998 Dec; 5(12):1604-11. PubMed ID: 10023439
[TBL] [Abstract][Full Text] [Related]
24. Femoral intra-arterial injection: a tool to deliver and assess recombinant AAV constructs in rodents whole hind limb.
Gonin P; Arandel L; Van Wittenberghe L; Marais T; Perez N; Danos O
J Gene Med; 2005 Jun; 7(6):782-91. PubMed ID: 15693034
[TBL] [Abstract][Full Text] [Related]
25. Localized gene expression following administration of adeno-associated viral vectors via pancreatic ducts.
Loiler SA; Tang Q; Clarke T; Campbell-Thompson ML; Chiodo V; Hauswirth W; Cruz P; Perret-Gentil M; Atkinson MA; Ramiya VK; Flotte TR
Mol Ther; 2005 Sep; 12(3):519-27. PubMed ID: 15979413
[TBL] [Abstract][Full Text] [Related]
26. Major role of local immune responses in antibody formation to factor IX in AAV gene transfer.
Wang L; Cao O; Swalm B; Dobrzynski E; Mingozzi F; Herzog RW
Gene Ther; 2005 Oct; 12(19):1453-64. PubMed ID: 15889137
[TBL] [Abstract][Full Text] [Related]
27. Lack of an immune response against the tetracycline-dependent transactivator correlates with long-term doxycycline-regulated transgene expression in nonhuman primates after intramuscular injection of recombinant adeno-associated virus.
Favre D; Blouin V; Provost N; Spisek R; Porrot F; Bohl D; Marmé F; Chérel Y; Salvetti A; Hurtrel B; Heard JM; Rivière Y; Moullier P
J Virol; 2002 Nov; 76(22):11605-11. PubMed ID: 12388721
[TBL] [Abstract][Full Text] [Related]
28. Efficient transduction of skeletal muscle using vectors based on adeno-associated virus serotype 6.
Blankinship MJ; Gregorevic P; Allen JM; Harper SQ; Harper H; Halbert CL; Miller AD; Chamberlain JS
Mol Ther; 2004 Oct; 10(4):671-8. PubMed ID: 15451451
[TBL] [Abstract][Full Text] [Related]
29. [Regulation of AAV-mediated glial cell-line derived neurotrophic factor expression by using improved Tet-on trans-activator].
Chen T; Li XG; Wu CY; Takashi O; Keiya O
Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(6):405-8. PubMed ID: 15854532
[TBL] [Abstract][Full Text] [Related]
30. Salivary glands as a potential gene transfer target for gene therapeutics of some monogenetic endocrine disorders.
Voutetakis A; Bossis I; Kok MR; Zhang W; Wang J; Cotrim AP; Zheng C; Chiorini JA; Nieman LK; Baum BJ
J Endocrinol; 2005 Jun; 185(3):363-72. PubMed ID: 15930162
[TBL] [Abstract][Full Text] [Related]
31. Correction of glycogen storage disease type II by an adeno-associated virus vector containing a muscle-specific promoter.
Sun B; Zhang H; Franco LM; Brown T; Bird A; Schneider A; Koeberl DD
Mol Ther; 2005 Jun; 11(6):889-98. PubMed ID: 15922959
[TBL] [Abstract][Full Text] [Related]
32. Activator protein 1-mediated transcriptional regulation strategy sustains long-term expression of a xenogeneic gene product in vivo: an implication for gene therapy targeting congenital protein deficiencies.
Sasaki S; Smith JM; Takase K; Okuda K; Ishii N; Takeshita F
Int J Mol Med; 2006 Aug; 18(2):289-97. PubMed ID: 16820937
[TBL] [Abstract][Full Text] [Related]
33. Adeno-associated virus vector-mediated gene transfer into dystrophin-deficient skeletal muscles evokes enhanced immune response against the transgene product.
Yuasa K; Sakamoto M; Miyagoe-Suzuki Y; Tanouchi A; Yamamoto H; Li J; Chamberlain JS; Xiao X; Takeda S
Gene Ther; 2002 Dec; 9(23):1576-88. PubMed ID: 12424610
[TBL] [Abstract][Full Text] [Related]
34. Tight control of gene expression by a helper-dependent adenovirus vector carrying the rtTA2(s)-M2 tetracycline transactivator and repressor system.
Salucci V; Scarito A; Aurisicchio L; Lamartina S; Nicolaus G; Giampaoli S; Gonzalez-Paz O; Toniatti C; Bujard H; Hillen W; Ciliberto G; Palombo F
Gene Ther; 2002 Nov; 9(21):1415-21. PubMed ID: 12378403
[TBL] [Abstract][Full Text] [Related]
35. Improved transduction of primary murine hepatocytes by recombinant adeno-associated virus 2 vectors in vivo.
Zhong L; Li W; Yang Z; Chen L; Li Y; Qing K; Weigel-Kelley KA; Yoder MC; Shou W; Srivastava A
Gene Ther; 2004 Jul; 11(14):1165-9. PubMed ID: 15164097
[TBL] [Abstract][Full Text] [Related]
36. Tightly regulated long-term erythropoietin expression in vivo using tet-inducible recombinant adeno-associated viral vectors.
Rendahl KG; Quiroz D; Ladner M; Coyne M; Seltzer J; Manning WC; Escobedo JA
Hum Gene Ther; 2002 Jan; 13(2):335-42. PubMed ID: 11812288
[TBL] [Abstract][Full Text] [Related]
37. Highly controlled gene expression using combinations of a tissue-specific promoter, recombinant adenovirus and a tetracycline-regulatable transcription factor.
Ghersa P; Gobert RP; Sattonnet-Roche P; Richards CA; Merlo Pich E; Hooft van Huijsduijnen R
Gene Ther; 1998 Sep; 5(9):1213-20. PubMed ID: 9930322
[TBL] [Abstract][Full Text] [Related]
38. Stable therapeutic serum levels of human alpha-1 antitrypsin (AAT) after portal vein injection of recombinant adeno-associated virus (rAAV) vectors.
Song S; Embury J; Laipis PJ; Berns KI; Crawford JM; Flotte TR
Gene Ther; 2001 Sep; 8(17):1299-306. PubMed ID: 11571566
[TBL] [Abstract][Full Text] [Related]
39. Recombinant adeno-associated virus vector-transduced vascular endothelial cells express the thrombomodulin transgene under the regulation of enhanced plasminogen activator inhibitor-1 promoter.
Mimuro J; Muramatsu S; Hakamada Y; Mori K; Kikuchi J; Urabe M; Madoiwa S; Ozawa K; Sakata Y
Gene Ther; 2001 Nov; 8(22):1690-7. PubMed ID: 11892836
[TBL] [Abstract][Full Text] [Related]
40. rAAV vector-mediated sarcogylcan gene transfer in a hamster model for limb girdle muscular dystrophy.
Li J; Dressman D; Tsao YP; Sakamoto A; Hoffman EP; Xiao X
Gene Ther; 1999 Jan; 6(1):74-82. PubMed ID: 10341878
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
